Delivery Systems for Gene-based Vaccines (original) (raw)

• Dubensky TW, Campbell BA, Villarreal LP. (1984) Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc. Natl. Acad. Sci. U.S.A. 81: 7529–7533.
  Article CAS Google Scholar
• Benvenisty N, Reshef L. (1986) Direct introduction of genes into rats and expression of the genes. Proc. Natl. Acad. Sci. U.S.A. 83: 9551–9555.
  Article CAS Google Scholar
• Wolff JA, Malone RW, Williams P, et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468.
  Article CAS Google Scholar
• Tang DC, De Vit M, Johnston SA. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152–154.
  Article CAS Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE, et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
  Article CAS Google Scholar
• Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. (1997) DNA vaccines. Annu. Rev. Immunol. 15: 617–648.
  Article CAS Google Scholar
• Haas J, Park EC, Seed B. (1996) Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6: 315–324.
  Article CAS Google Scholar
• Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J. (1998) Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72: 1497–1503.
  CAS PubMed PubMed Central Google Scholar
• Chen MC, Doe B, Schaefer M, et al. (2000) Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J. Virol. 74: 2628–2635.
  Article Google Scholar
• Uchijima M, Yoshida A, Nagata T, Koide Y. (1998) Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J. Immunol. 161: 5594–5599.
  CAS PubMed Google Scholar
• Hartikka J, Sawdey M, Cornefert-Jensen F, et al. (1996) An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene. Ther. 7: 1205–1217.
  Article CAS Google Scholar
• Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS. (1997) Promoter attenuation in gene therapy: interferon-γ and tumor necrosis factor-α inhibit transgene expression. Hum. Gene Ther. 8: 2019–2029.
  Article CAS Google Scholar
• Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161: 3042–3049.
  CAS PubMed Google Scholar
• Boyle JS, Koniaras C, Lew AM. (1997) Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 9: 1897–1906.
  Article CAS Google Scholar
• Baldwin SL, D’Souza CD, Orme IM, et al. (1999) Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. Tuber. Lung. Dis. 79: 251–259.
  Article CAS Google Scholar
• McClements WL, Armstrong ME, Keys RD, Liu MA. (1996) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. U.S.A. 93: 11414–11420.
  Article CAS Google Scholar
• Tobery T, Siliciano R. (1997) Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185: 909–920.
  Article CAS Google Scholar
• Rodriguez F, Zhang J, Whitton J. (1997) DNA immunization: ubiquitination of a viral protein enhances cytotoxic T lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71: 8497–8503.
  CAS PubMed PubMed Central Google Scholar
• Fu TM, Guan L, Friedman A, Ulmer JB, Liu MA, Donnelly JJ. (1998) Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens. Vaccine 16: 1711–1717.
  Article CAS Google Scholar
• Vidalin O, Tanaka E, Spengler U, Trepo C, Inchauspe G. (1999) Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination. DNA Cell Biol. 18: 611–621.
  Article CAS Google Scholar
• Boyle JS, Brady JL, Lew AM. (1998) Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392: 408–411.
  Article CAS Google Scholar
• Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW. (1999) Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity [see comments]. Nat. Biotechnol. 17: 253–258.
  Article CAS Google Scholar
• Sasaki S, Tsuji T, Asakura Y, Fukushima J, Okuda K. (1998) The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants. Anticancer Res. 18: 3907–3915.
  CAS PubMed Google Scholar
• Agadjanyan MG, Kim JJ, Trivedi N, et al. (1999) CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J. Immunol. 162: 3417–3427.
  CAS PubMed Google Scholar
• Ulmer JB, DeWitt CM, Chastain M, et al. (1999) Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 18: 18–28.
  Article CAS Google Scholar
• Klinman D, Yamshchikov G, Ishigatsubo Y. (1997) Contribution of CpG Motifs to the Immunogenicity of DNA Vaccines. J. Immunol. 158: 3635–3639.
  CAS PubMed Google Scholar
• Sato Y, Roman M, Tighe H, et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352–354.
  Article CAS Google Scholar
• Krieg AM, Wu T, Weeratna R, et al. (1998) Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci U.S.A. 95: 12631–12636.
  Article CAS Google Scholar
• Weeratna R, Brazolot MC, Krieg AM, Davis HL. (1998) Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 8: 351–356.
  Article CAS Google Scholar
• Nichols WW, Ledwith BJ, Manam SV, Troilo PJ. (1995) Potential DNA vaccine integration into host cell genome. Ann. NY Acad. Sci. 772: 30–39.
  Article CAS Google Scholar
• Chattergoon MA, Robinson TM, Boyer JD, Weiner DB. (1998) Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigenpresenting cells. J. Immunol. 160: 5707–5718.
  CAS PubMed Google Scholar
• Akbari O, Panjwani N, Garcia S, Tascon R, Lowrie D, Stockinger B. (1999) DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med. 189: 169–178.
  Article CAS Google Scholar
• Bouloc A, Walker P, Grivel JC, Vogel JC, Katz SI. (1999) Immunization through dermal delivery of protein-encoding DNA: a role for migratory dendritic cells. Eur. J. Immunol. 29: 446–454.
  Article CAS Google Scholar
• Mathiesen I. (1999) Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6: 508–514.
  Article CAS Google Scholar
• Widera G, Austin M, Rabussay D, et al. (2000) Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164: 4635–4640.
  Article CAS Google Scholar
• Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961–965.
  Article CAS Google Scholar
• Ulmer JB, Deck RR, DeWitt CM, Donnhly JI, Liu MA. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89: 59–67.
  Article CAS Google Scholar
• Fu TM, Ulmer JB, Caulfield MJ, et al. (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3: 362–371.
  Article CAS Google Scholar
• Timares L, Takashima A, Johnston SA. (1998) Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 95: 13147–13152.
  Article CAS Google Scholar
• Loirat D, Li Z, Mancini M, Tiollais P, Paulin D, Michel ML. (1999) Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology 260: 74–83.
  Article CAS Google Scholar
• Manickan E, Kanangat S, Rouse RJ, Yu Z, Rouse BT. (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukocyte Biol. 61: 125–132.
  Article CAS Google Scholar
• Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA. (1997) Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186: 1481–1486.
  Article CAS Google Scholar
• Singh M, Briones M, Ott GS, O’Hagan DT. (2000) Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl. Acad. Sci. U.S.A. 97: 811–816.
  Article CAS Google Scholar
• Dubensky TW, Polo JM, Jolly DJ. (2000) Alphavirus-based vectors for vaccine and gene therapy applications. In: GeneTherapy: Therapeutic Mechanisms and Strategies. eds. N.S. Templeton and D.D. Lasic (New York; Marcel Dekker, Inc., 2000): 103–109.
  Google Scholar
• Schlesinger S, Dubensky TW. (1999) Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol. 10: 434–439.
  Article CAS Google Scholar
• Strauss JH, Strauss EG. (1994) The alphaviruses: gene expression, replication, and evolution [published erratum appears in Microbiol. Rev. 1994, 58:806]. Microbiol. Rev. 58: 491–562.
  CAS PubMed PubMed Central Google Scholar
• Driver DA, Polo JM, Belli BA, et al. (1996) Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J. Virol. 70: 508–519.
  PubMed PubMed Central Google Scholar
• Berglund P, Smerdou C, Fleeton MN, Tubulekas I, Liljestrom P. (1998) Enhancing immune responses using suicidal DNA vaccines [see comments]. Nat. Biotechnol. 16: 562–565.
  Article CAS Google Scholar
• Herweijer H, Latendresse JS, Williams P, et al. (1995) A plasmid-based self-amplifying Sindbis virus vector. Hum. Gene Ther. 6: 1161–1167.
  Article CAS Google Scholar
• Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S. (1993) Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67: 6439–6446.
  CAS PubMed PubMed Central Google Scholar
• Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF. (1997) Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239: 389–401.
  Article CAS Google Scholar
• Polo JM, Belli BA, Driver DA, et al. (1999) Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. U.S.A. 96: 4598–4603.
  Article CAS Google Scholar
• Smerdou C, Liljestrom P. (1999) Two-helper RNA system for production of recombinant Semliki Forest virus particles. J. Virol. 73: 1092–1098.
  CAS PubMed PubMed Central Google Scholar
• Hariharan MJ, Driver DA, Townsend K, et al. (1998) DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J. Virol. 72: 950–958.
  CAS PubMed PubMed Central Google Scholar
• Leitner WW, Ying H, Driver DA, Dubensky TW, Restifo NP. (2000) Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 60: 51–55.
  CAS PubMed PubMed Central Google Scholar
• Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. (1999) Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821–829.
  Article CAS Google Scholar
• Albert ML, Sauter B, Bhardwaj N. (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86–89.
  Article CAS Google Scholar
• Zhou X, Berglund P, Zhao H, Liljestrom P, Jondal M. (1995) Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Proc. Natl. Acad. Sci. U.S.A. 92: 3009–3013.
  Article CAS Google Scholar
• Davis NL, Brown KW, Johnston RE. (1996) A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70: 3781–3787.
  CAS PubMed PubMed Central Google Scholar
• Berglund P, Fleeton MN, Smerdou C, Liljestrom P. (1999) Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice. Vaccine 17: 497–507.
  Article CAS Google Scholar
• Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A. (1998) Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251: 28–37.
  Article CAS Google Scholar
• Berglund P, Quesada-Rolander M, Putkonen P, Biberfeld G, Thorstensson R, Liljestrom P. (1997) Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res. Hum. Retroviruses 13: 1487–1495.
  Article CAS Google Scholar
• Mossman SP, Bex F, Berglund P, et al. (1996) Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J. Virol. 70: 1953–1960.
  CAS PubMed PubMed Central Google Scholar
• Davis NL, Caley IJ, Brown KW, et al. (2000) Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J. Virol. 74: 371–378.
  Article CAS Google Scholar
• MacDonald GH, Johnston RE. (2000) Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J. Virol. 74: 914–922.
  Article CAS Google Scholar
• Borrow P, Evans CF, Oldstone MB. (1995) Virus-induced immunosuppression: immune systemmediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69: 1059–1070.
  CAS PubMed PubMed Central Google Scholar
• Tuittila MT, Santagati MG, Roytta M, Maatta JA, Hinkkanen AE. (2000) Replicase complex genes of Semliki Forest virus confer lethal neurovirulence. J. Virol. 74: 4579–4589.
  Article CAS Google Scholar
• Hanke T, Samuel RV, Blanchard TJ, et al. (1999) Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J. Virol. 73: 7524–7532.
  CAS PubMed PubMed Central Google Scholar
• Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA. (1998) Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72: 10180–10188.
  CAS PubMed PubMed Central Google Scholar